Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Yang

Showing results (1331-1340 of 1,365) with videos related to

Pageof 137
Sort By:
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
The discovery of sulfonylated dipeptides as potent VLA-4 antagonistsW K Hagmann, P L Durette, T Lanza, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|December 6, 2018
[Multicenter investigation of extracorporeal membrane oxygenation application in pediatric intensive care unit in China]G F Yan, X D Cai, C B Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2011
Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort ConsortiumP Boffetta, W D Hazelton, Y Chen, et al.
Journal of Medicinal Chemistry|December 23, 2016
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P<sub>1</sub> Receptor ModulatorMichael G Yang, Zili Xiao, T G Murali Dhar, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and PsoriasisQingjie Liu, Hai-Yun Xiao, Douglas G Batt, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015: results from a multicenter, retrospective study]Y K Wan, W Sang, B Chen, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
Journal of Medicinal Chemistry|February 21, 2019
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Modulator Advanced into Clinical TrialsJohn L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Physical Review Letters|July 1, 2022
Probing ^{93m}Mo Isomer Depletion with an Isomer BeamS Guo, B Ding, X H Zhou, et al.
Pageof 137

Showing results (1331-1340 of 1,365) with videos related to

Sort By:
Pageof 137
Bioorganic & Medicinal Chemistry Letters|October 10, 2001
The discovery of sulfonylated dipeptides as potent VLA-4 antagonistsW K Hagmann, P L Durette, T Lanza, et al.
Zhonghua Er Ke Za Zhi = Chinese Journal of Pediatrics|December 6, 2018
[Multicenter investigation of extracorporeal membrane oxygenation application in pediatric intensive care unit in China]G F Yan, X D Cai, C B Zhou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 8, 2011
Body mass, tobacco smoking, alcohol drinking and risk of cancer of the small intestine--a pooled analysis of over 500,000 subjects in the Asia Cohort ConsortiumP Boffetta, W D Hazelton, Y Chen, et al.
Journal of Medicinal Chemistry|December 23, 2016
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P<sub>1</sub> Receptor ModulatorMichael G Yang, Zili Xiao, T G Murali Dhar, et al.
ACS Medicinal Chemistry Letters|May 31, 2021
Azatricyclic Inverse Agonists of RORγt That Demonstrate Efficacy in Models of Rheumatoid Arthritis and PsoriasisQingjie Liu, Hai-Yun Xiao, Douglas G Batt, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[Distribution and drug resistance of pathogens at hematology department of Jiangsu Province from 2014 to 2015: results from a multicenter, retrospective study]Y K Wan, W Sang, B Chen, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
Journal of Medicinal Chemistry|February 21, 2019
Identification and Preclinical Pharmacology of ((1 R,3 S)-1-Amino-3-(( S)-6-(2-methoxyphenethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986166): A Differentiated Sphingosine-1-phosphate Receptor 1 (S1P<sub>1</sub>) Modulator Advanced into Clinical TrialsJohn L Gilmore, Hai-Yun Xiao, T G Murali Dhar, et al.
Blood|January 6, 2026
Harnessing the CD2 axis to broaden and enhance the efficacy of CAR T-cell therapiesAlberto Carturan, Mathew G Angelos, Puneeth Guruprasad, et al.
Physical Review Letters|July 1, 2022
Probing ^{93m}Mo Isomer Depletion with an Isomer BeamS Guo, B Ding, X H Zhou, et al.
Pageof 137